Six months ended June 30,

2015

2014

Cash paid for interest

$

25,356

$

152,813

Series C Dividend payable in accrued expenses

$

--

$

17,870

Series D Dividend payable in accrued expenses

$

26,555

$

49,237

Non-Cash investing and financing transactions

Shares issued for consulting services

$

25,500

$

--

Beneficial conversion feature on warrants issued in conjunction with Series D preferred shares

$

--

$

24,279

Shares issued in acquisition of Dr. Pave

$

--

$

175,000